Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Price to Book Value : 2.971 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.971 |
| August 21, 2026 | 3.031 |
| August 20, 2026 | 3.056 |
| August 19, 2026 | 3.113 |
| August 18, 2026 | 3.119 |
| August 17, 2026 | 3.165 |
| August 14, 2026 | 3.185 |
| August 13, 2026 | 3.684 |
| August 12, 2026 | 3.699 |
| August 11, 2026 | 3.709 |
| August 10, 2026 | 3.700 |
| August 07, 2026 | 3.709 |
| August 06, 2026 | 3.676 |
| August 05, 2026 | 3.708 |
| August 04, 2026 | 3.750 |
| August 03, 2026 | 3.818 |
| July 31, 2026 | 3.893 |
| July 30, 2026 | 3.830 |
| July 29, 2026 | 3.818 |
| July 28, 2026 | 3.853 |
| July 27, 2026 | 3.956 |
| July 24, 2026 | 3.982 |
| July 23, 2026 | 3.853 |
| July 22, 2026 | 3.833 |
| July 21, 2026 | 3.894 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.956 |
| July 17, 2026 | 3.989 |
| July 16, 2026 | 4.100 |
| July 15, 2026 | 3.852 |
| July 14, 2026 | 3.821 |
| July 13, 2026 | 3.750 |
| July 10, 2026 | 3.788 |
| July 09, 2026 | 3.768 |
| July 08, 2026 | 3.792 |
| July 07, 2026 | 3.736 |
| July 06, 2026 | 3.699 |
| July 02, 2026 | 3.504 |
| July 01, 2026 | 3.696 |
| June 30, 2026 | 3.752 |
| June 29, 2026 | 4.302 |
| June 26, 2026 | 4.304 |
| June 25, 2026 | 4.193 |
| June 24, 2026 | 4.029 |
| June 23, 2026 | 3.943 |
| June 22, 2026 | 3.948 |
| June 18, 2026 | 3.921 |
| June 17, 2026 | 4.019 |
| June 16, 2026 | 4.018 |
| June 15, 2026 | 4.003 |
| June 12, 2026 | 3.694 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 2.814 |
| Daré Bioscience, Inc. | -- |
| Eton Pharmaceuticals, Inc. | 38.39 |
| ANI Pharmaceuticals, Inc. | 2.877 |
| Corcept Therapeutics, Inc. | 18.78 |
Price to Book Value Related Metrics
| PE Ratio | 10.99 |
| PS Ratio | 2.300 |
| Price to Free Cash Flow | 18.51 |
| Price | 0.2891 |
| Earnings Yield | 9.10% |
| Market Cap | 311.40M |
| Operating PE Ratio | 9.064 |
| Normalized PE Ratio | 35.69 |